San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

With a longtime vaccine skeptic serving as the country’s top health official, the movement is likely to make further inroads.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

The global cholesterol API market is witnessing robust growth, driven by the expanding application of cholesterol-based raw materials across pharmaceuticals, biotechnology, cosmetics, and advanced ...

Those state efforts, alongside separate measures to limit or ban the use of messenger RNA vaccines like those developed for Covid, come amid longtime vaccine skeptic Robert F. Kennedy Jr.’s ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

(Reuters) -The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...